These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 22580389

  • 21. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.
    Tarantino MD, Madden RM, Fennewald DL, Patel CC, Bertolone SJ.
    J Pediatr; 1999 Jan; 134(1):21-6. PubMed ID: 9880444
    [Abstract] [Full Text] [Related]

  • 22. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG.
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [Abstract] [Full Text] [Related]

  • 23. Randomized trial of high-dose methylprednisolone versus intravenous immunoglobulin for the treatment of acute idiopathic thrombocytopenic purpura in children.
    Ancona KG, Parker RI, Atlas MP, Prakash D.
    J Pediatr Hematol Oncol; 2002 Oct; 24(7):540-4. PubMed ID: 12368690
    [Abstract] [Full Text] [Related]

  • 24. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura.
    Blanchette V, Carcao M.
    Transfus Sci; 1998 Sep; 19(3):279-88. PubMed ID: 10351140
    [Abstract] [Full Text] [Related]

  • 25. Predictive factors of response to IVIG in pediatric immune thrombocytopenic purpura.
    Higashide Y, Hori T, Yoto Y, Kabutoya H, Honjo S, Sakai Y, Nojima M, Yoda M, Yamamoto M, Tsutsumi H.
    Pediatr Int; 2018 Apr; 60(4):357-361. PubMed ID: 29297955
    [Abstract] [Full Text] [Related]

  • 26. An analysis of outcomes and treatment costs for children undergoing splenectomy for chronic immune thrombocytopenia purpura.
    Gwilliam NR, Lazar DA, Brandt ML, Mahoney DH, Wesson DE, Mazziotti MV, Nuchtern JG, Lee TC.
    J Pediatr Surg; 2012 Aug; 47(8):1537-41. PubMed ID: 22901913
    [Abstract] [Full Text] [Related]

  • 27. Recent advances in the treatment of childhood immune thrombocytopenic purpura.
    Tarantino M.
    Semin Hematol; 2006 Jul; 43(3 Suppl 5):S11-7; discussion S18-9. PubMed ID: 16815345
    [Abstract] [Full Text] [Related]

  • 28. Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia.
    Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F.
    Blood Adv; 2022 Feb 08; 6(3):785-792. PubMed ID: 34781363
    [Abstract] [Full Text] [Related]

  • 29. Splenectomy for chronic idiopathic thrombocytopenic purpura in children: a single center study in China.
    Wang T, Xu M, Ji L, Yang R.
    Acta Haematol; 2006 Feb 08; 115(1-2):39-45. PubMed ID: 16424648
    [Abstract] [Full Text] [Related]

  • 30. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
    Ou CY, Hsieh KS, Chiou YH, Chang YH, Ger LP.
    Acta Paediatr Taiwan; 2006 Feb 08; 47(5):226-31. PubMed ID: 17352309
    [Abstract] [Full Text] [Related]

  • 31. Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity.
    Güngör T, Arman Bilir Ö, Koşan Çulha V, Güngör A, Kara A, Azık FM, Yaralı HN.
    Pediatr Neonatol; 2019 Aug 08; 60(4):411-416. PubMed ID: 30470618
    [Abstract] [Full Text] [Related]

  • 32. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.
    Blanchette V, Imbach P, Andrew M, Adams M, McMillan J, Wang E, Milner R, Ali K, Barnard D, Bernstein M.
    Lancet; 1994 Sep 10; 344(8924):703-7. PubMed ID: 7915773
    [Abstract] [Full Text] [Related]

  • 33. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial.
    Benesch M, Kerbl R, Lackner H, Berghold A, Schwinger W, Triebl-Roth K, Urban C.
    J Pediatr Hematol Oncol; 2003 Oct 10; 25(10):797-800. PubMed ID: 14528103
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura.
    Fujisawa K, Iyori H, Ohkawa H, Konishi S, Bessho F, Shirahata A, Miyazaki S, Akatsuka J, Japanese Study Group on Childhood ITP.
    Int J Hematol; 2000 Oct 10; 72(3):376-83. PubMed ID: 11185998
    [Abstract] [Full Text] [Related]

  • 38. How far should we go with cost-utility analysis when treating children with acute idiopathic thrombocytopenic purpura?
    Benesch M.
    Pediatr Blood Cancer; 2008 Feb 10; 50(2):433. PubMed ID: 17458876
    [No Abstract] [Full Text] [Related]

  • 39. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Lioger B, Maillot F, Ternant D, Passot C, Paintaud G, Bejan-Angoulvant T.
    J Pediatr; 2019 Jan 10; 204():225-233.e8. PubMed ID: 30314658
    [Abstract] [Full Text] [Related]

  • 40. Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia.
    Zeller MP, Heddle NM, Kelton JG, Hamilton K, Wang G, Sholapur N, Carruthers J, Hsia C, Blais N, Toltl L, Hamm C, Pearson MA, Arnold DM.
    Transfusion; 2016 Jan 10; 56(1):73-9. PubMed ID: 26400824
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.